Biocon expands US portfolio with Bosaya & Aukelso biosimilars, offering affordable treatments for bone conditions. FDA-approved, now...
medical devices
India's rising trend of using weight-loss drugs like Mounjaro for cosmetic reasons sparks ethical debates and investment...
FDA approves Eli Lilly's Foundayo for weight loss, intensifying competition with Novo Nordisk. A new oral option...
Explore the challenges of AI integration in Indian healthcare. Learn how AI can improve diagnostics and patient...
Lupin receives tentative USFDA approval for generic Sugammadex injection, a muscle relaxant reversal agent. Key step in...
Dr. Reddy's Laboratories secures temporary legal approval to market its semaglutide brand 'Olymviq' for 30 days. A...
NovaBay Pharmaceuticals rebrands to Stablecoin Development Corporation, signaling a shift towards blockchain and digital assets. Details on...
India's healthcare sector aims for $700 billion by 2030, facing financing and infrastructure challenges. Public-private partnerships are...
India's drug regulator increases scrutiny of GLP-1 weight loss drugs due to unauthorized sales and improper prescriptions....
Delhi's healthcare sector expands with 1,288 new hospital beds and improved emergency response. Addressing rising demand and...